Nicole Caston

Jun 28, 2024 | ascopubs.org | Gabrielle B. Rocque |Nicole Caston |Nicole Henderson

1-4 The recent PRO-TECT trial, which cluster randomized 52 community oncology practices across 21 states to RSM versus usual care, found that patients receiving RSM had improved quality of life, symptom control, and physical function.3 Furthermore, RSM was acceptable to patients as 90% of participating patients endorsed recommending the program to others.5 Because of the success across these and other studies, collection of ePROs is included as a requirement for oncology practices...

Apr 17, 2024 | onlinelibrary.wiley.com | Luqin Deng |Nicole Caston |Kathleen Gallagher

1 BACKGROUND Cancer clinical trials test the safety and efficacy of new therapies, technologies, interventions or new delivery, dosing, or sequencing of approved therapies to prevent, detect, or treat cancer.